In recent years, the weight loss category has become stagnant and saturated with the standard variety caffeine-filled thermogenic supplements. Purus Labs answered the need for innovation and discovered TheaTrim, the world’s first thermogenic that contains TeaCrine. TeaCrine is a natural purine alkaloid extracted from kucha tea that acts on both adenosinergic and dopaminergic pathways to reduce fatigue, increase energy, improve concentration, and support fat loss.
There’s no question that caffeine is an effective thermogenic weight loss aid. It stimulates the central nervous system to release adrenaline, resulting in mobilization of fat cells for energy production and a higher metabolism. The problem with caffeine is that it becomes less effective over time as the body adapts and becomes desensitized.
TeaCrine (a patented source of theacrine) is structurally similar to caffeine, but its effect on the body does not appear to weaken over time. TeaCrine acts on adenosine and dopamine receptors, favorably impacting psychometric measures such as energy, concentration, endurance, and overall sense of well-being. It also provides benefits as an anti-inflammatory and analgesic.
In addition to caffeine and TeaCrine, TheaTrim also features impressive compounds such as rauwolscine, or alpha-yohimbine. This compound is an alpha2-adrenergic receptor agonist. By inhibiting this specific receptor, TheaTrim encourages the mobilization of fat for energy production, resulting in significant weight loss.
Purus Labs has worked closely with The Center For Applied Health Sciences to develop TheaTrim. The combination of TeaCrine and other proven, synergistic materials will help users experience a boost in weight loss, energy, and overall well being.
TheaTrim is a thermogenic weight loss and mental acuity aid that blends the stimulatory effects of standard thermogenics with the weight loss benefits of TeaCrine, a revolutionary new ingredient.
Take 1 to 2 caps up to two times per day with food. Take at least 4-5 hours apart.
Do not take TheaTrim in excess of recommended dosage. Only intended for healthy adults over the age of 21. May acutely elevate heart rate and blood pressure. Do not use if you are pregnant or nursing. Keep out of reach of children.
TeaCrine – TeaCrine is a naturally occurring pure alkaloid present in Camellia assamica kucha tea that acts on adenosinergic and dopaminergic pathways to cause significant improvements in energy and weight loss.
White Willow Bark – White willow bark contains salicin, a compound similar to aspirin. White willow has been shown to work effectively as a weight and fat loss aid when combined with compounds such as caffeine.
Infinergy Dicaffeine Malate – This is a mild stimulant that contains both caffeine and malic acid. It is effective in stimulating the central nervous system to release adrenaline and promote weight loss. The malic acid portion allows it to be more gentle on the stomach, reducing common side effects of caffeine.
Citrus Bioflavonoid Complex – This compound contains an endogenous proteins that inhibits an enzyme known as CYP450. By preventing the break down of certain substances such as caffeine, it increases and extends the active life of these molecules.
Rauwolfia – Rauwolfia, root bark extract, is an alpha-2 adrenergic receptor agonist. Activation of these receptors inhibits fat loss, and by inhibiting them, rauwolfia creates an ideal scenario for fat breakdown and weight loss.
-  Astrup A, et al. “Caffeine: A Double-Blind, Placebo-Controlled Study of its Thermogenic, Metabolic, and Cardiovascular Effects in Healthy Volunteers.” The American Journal of Clinical Nutrition. 51:5. (1990): 759-767.
-  Feduccia AA, et al. Locomotor Activation by Theacrine, a Purine Alkaloid Structurally Similar to Caffeine: Involvement of Adenosine and Dopamine Receptors. Pharmacology Biochemistry and Behavior. 102:2. (2012): 241-248.
-  Wang Y, et al. Theacrine, a Purine Alkaloid with Anti-Inflammatory and Analgesic Activities. Fitoterapia. 81:6. (2010): 627-631.
-  Perry BD, U’Prichard DC. [3H]rauwolscine (?-yohimbine): A Specific Antagonist Radioligand for Brain ?2-Adrenergic Receptors. European Journal of Pharmacology. 76:4. (1981): 461-464.